Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI - Quiz - MDSpire

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

  • By

  • Yang Gao

  • Jiangnian Gong

  • Yuanling Yang

  • Yingyi Luo

  • Weiyi Liu

  • Zisan Zeng

  • February 13, 2026

  • 0 min

Share

Original Source(s)

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

  • by Yang Gao, Jiangnian Gong, Yuanling Yang, Yingyi Luo, Weiyi Liu, Zisan Zeng

  • February 13, 2026

Related Content

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.